Rigel Pharmaceuticals, Inc.
NASDAQ:RIGL
19.28 (USD) • At close July 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 179.278 | 116.882 | 120.242 | 149.236 | 108.621 | 59.288 | 44.509 | 4.484 | 20.383 | 28.895 | 8.25 | 7.15 | 2.25 | 4.75 | 125 | 0.75 | 0 | 12.6 | 33.473 | 16.526 | 4.733 | 11.055 | 15.788 | 15.303 | 13.218 | 8.984 |
| Cost of Revenue
| 18.647 | 7.11 | 1.749 | 1.083 | 0.895 | 0.906 | 0.287 | 46.269 | 63.446 | 62.825 | 67.696 | 75.328 | 78.778 | 0 | 0 | 1.403 | 1.425 | 0 | 0 | 1.15 | 0 | 0 | 0 | 0 | -7.557 | -1.906 |
| Gross Profit
| 160.631 | 109.772 | 118.493 | 148.153 | 107.726 | 58.382 | 44.222 | -41.785 | -43.063 | -33.93 | -59.446 | -68.178 | -76.528 | 4.75 | 125 | 0.75 | 0 | 12.6 | 33.473 | 16.526 | 4.733 | 11.055 | 15.788 | 15.303 | 20.775 | 10.89 |
| Gross Profit Ratio
| 0.896 | 0.939 | 0.985 | 0.993 | 0.992 | 0.985 | 0.994 | -9.319 | -2.113 | -1.174 | -7.206 | -9.535 | -34.012 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.572 | 1.212 |
| Reseach & Development Expenses
| 23.38 | 24.522 | 60.272 | 65.237 | 60.101 | 52.885 | 46.903 | 46.269 | 63.446 | 62.825 | 67.696 | 75.328 | 78.778 | 69.35 | 64.392 | 90.743 | 109.67 | 70.364 | 56.968 | 52.038 | 48.523 | 43.363 | 43.35 | 32.313 | 32.034 | 17.112 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 70.002 | 37.831 | 20.908 | 17.813 | 31.803 | 19.612 | 22.849 | 21.768 | 25.291 | 20.903 | 27.044 | 21.763 | 19.552 | 12.41 | 13.077 | 8.519 | 9.454 | 7.95 | 6.689 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 113.059 | 105.741 | 112.451 | 91.891 | 76.598 | 74.588 | 70.002 | 37.831 | 20.908 | 17.813 | 31.803 | 19.612 | 22.849 | 21.768 | 25.291 | 20.903 | 27.044 | 21.763 | 19.552 | 12.41 | 13.077 | 8.519 | 9.454 | 7.95 | 6.689 | 3.952 |
| Other Expenses
| 0 | 0 | 1.32 | 0 | 0 | 0 | 0 | 0 | 5.77 | 0 | -9.302 | 1.679 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.557 | 1.906 |
| Operating Expenses
| 136.439 | 130.263 | 172.723 | 157.128 | 136.699 | 127.473 | 116.905 | 84.1 | 90.124 | 80.638 | 99.499 | 96.619 | 101.627 | 91.118 | 89.683 | 111.646 | 135.289 | 92.127 | 76.52 | 63.298 | 61.6 | 51.882 | 52.804 | 40.263 | 46.28 | 22.97 |
| Operating Income
| 24.192 | -20.491 | -55.55 | -8.975 | -28.973 | -69.091 | -72.683 | -79.616 | -69.741 | -51.743 | -91.249 | -89.469 | -99.377 | -86.368 | 35.317 | -112.037 | -136.714 | -79.527 | -43.047 | -47.922 | -56.867 | -40.827 | -37.016 | -24.96 | -25.505 | -12.08 |
| Operating Income Ratio
| 0.135 | -0.175 | -0.462 | -0.06 | -0.267 | -1.165 | -1.633 | -17.756 | -3.422 | -1.791 | -11.06 | -12.513 | -44.168 | -18.183 | 0.283 | -149.383 | 0 | -6.312 | -1.286 | -2.9 | -12.015 | -3.693 | -2.345 | -1.631 | -1.93 | -1.345 |
| Total Other Income Expenses Net
| -5.826 | -4.6 | -3.023 | -4.813 | -0.771 | 2.197 | 2.203 | 1.624 | 0.525 | 0.279 | 0.341 | 0.442 | 0.537 | 0.395 | 2.573 | 0.397 | 4.279 | 5.255 | 5.41 | 2.666 | 0.612 | -0.37 | -0.014 | 1.155 | 0.145 | 0 |
| Income Before Tax
| 18.366 | -25.091 | -58.573 | -17.309 | -29.744 | -66.894 | -70.48 | -77.992 | -69.216 | -51.464 | -90.908 | -89.027 | -98.84 | -85.973 | 37.89 | -111.64 | -132.435 | -74.272 | -37.637 | -45.256 | -56.255 | -41.197 | -37.03 | -23.805 | -25.36 | 0 |
| Income Before Tax Ratio
| 0.102 | -0.215 | -0.487 | -0.116 | -0.274 | -1.128 | -1.583 | -17.393 | -3.396 | -1.781 | -11.019 | -12.451 | -43.929 | -18.1 | 0.303 | -148.853 | 0 | -5.895 | -1.124 | -2.738 | -11.886 | -3.727 | -2.345 | -1.556 | -1.919 | 0 |
| Income Tax Expense
| 0.881 | 0 | 0 | 0.605 | 0 | -0.348 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.42 | 0.091 | -0.093 | -0.089 | 0 | 0 | 0 | 0 | 0.37 | 0 | 0 | 0 | 0.286 |
| Net Income
| 17.485 | -25.091 | -58.573 | -17.914 | -29.744 | -66.546 | -70.48 | -77.992 | -69.216 | -51.464 | -90.908 | -89.027 | -98.84 | -85.973 | 37.89 | -111.547 | -132.346 | -74.272 | -37.637 | -45.256 | -56.255 | -41.197 | -37.03 | -23.805 | -25.36 | -12.366 |
| Net Income Ratio
| 0.098 | -0.215 | -0.487 | -0.12 | -0.274 | -1.122 | -1.583 | -17.393 | -3.396 | -1.781 | -11.019 | -12.451 | -43.929 | -18.1 | 0.303 | -148.729 | 0 | -5.895 | -1.124 | -2.738 | -11.886 | -3.727 | -2.345 | -1.556 | -1.919 | -1.376 |
| EPS
| 0.99 | -1.44 | -3.4 | -1.05 | -1.8 | -4 | -4.4 | -6.17 | -7.33 | -5.82 | -10.37 | -10.2 | -2.46 | -3.67 | 1.62 | -2.73 | -3.67 | -2.57 | -1.51 | -2.07 | -3.12 | -3.62 | -7.31 | -5.75 | -31.43 | -355.49 |
| EPS Diluted
| 0.99 | -1.44 | -3.4 | -1.05 | -1.8 | -4 | -4.4 | -6.17 | -7.33 | -5.82 | -10.37 | -10.2 | -6.14 | -3.67 | 0.72 | -2.73 | -3.67 | -2.57 | -1.51 | -2.07 | -3.12 | -3.62 | -7.3 | -5.75 | -31.43 | -355.49 |
| EBITDA
| 28.512 | -16.981 | -53.868 | -11.287 | -27.685 | -65.876 | -69.886 | -77.527 | -63.03 | -50.304 | -88.89 | -85.198 | -96.944 | -83.993 | 39.298 | -110.034 | -130.85 | -79.527 | -41.629 | -46.742 | -54.494 | -37.65 | -31.192 | -18.2 | -17.948 | -10.174 |
| EBITDA Ratio
| 0.159 | -0.145 | -0.448 | -0.076 | -0.255 | -1.111 | -1.57 | -17.29 | -3.092 | -1.741 | -10.775 | -11.916 | -43.086 | -17.683 | 0.314 | -146.712 | 0 | -6.312 | -1.244 | -2.828 | -11.514 | -3.406 | -1.976 | -1.189 | -1.358 | -1.132 |